Mechanisms of transforming growth factor β1/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts

British Journal of Dermatology

Volumn 162, Issue 3, 2010, Pages 538-546

  He, S ^a   Liu, X ^b   Yang, Y ^a,b,c   Huang, W ^a   Xu, S ^a,c   Yang, S ^a,c   Zhang, X ^a,c   Roberts, M S ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Keloid fibroblasts; Mitogen activated protein kinase; Plasminogen activator inhibitor 1; Smad

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; KELOID; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; ANALYSIS OF VARIANCE; FIBROBLAST; FLUOROIMMUNOASSAY; HUMAN; METABOLISM;

ANALYSIS OF VARIANCE; FIBROBLASTS; FLUOROIMMUNOASSAY; HUMANS; IMMUNOBLOTTING; KELOID; MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 76949104807     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09511.x     Document Type: Article

References (39)

1. Murray JC, Pollack SV, Pinnell SR. Keloids: a review. J Am Acad Dermatol 1981 4 : 461 470.
2. Ghazizadeh M, Tosa M, Shimizu H et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol 2007 127 : 98 105. (Pubitemid 46005666)
3. English RS, Shenefelt PD. Keloid and hypertrophic scars. Dermatol Surg 1999 25 : 631 638.
4. Alster TS, Tanzi EL. Hypertrophic scars and keloids. Am J Clin Dermatol 2003 4 : 235 243.
5. Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 2005 153 : 295 300.
6. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004 188 : 16 27.
7. Hasegawa T, Nakao A, Sumiyoshi K et al. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts. J Dermatol Sci 2003 32 : 19 24.
8. Sandulache VC, Parekh A, Li-Korotky H et al. Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis. Wound Repair Regen 2007 15 : 122 133.
9. Tsuchihashi H, Hasegawa T, Sumiyoshi K et al. TWEAK inhibits TGF-beta-induced contraction of normal and keloid fibroblast-embedded collagen gel. J Dermatol Sci 2007 45 : 216 218.
10. Chin GS, Liu W, Peled Z et al. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 2001 108 : 423 429.
11. Phan TT, Lim IJ, Chan SY et al. Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. J Trauma 2004 57 : 1032 1037.
12. Phan TT, Lim IJ, Aalami O et al. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol 2005 207 : 232 242.
13. Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000 191 : 745 754.
14. Lim IJ, Phan TT, Tan EK et al. Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids. J Biol Chem 2003 278 : 40851 40858.
15. Xia W, Phan TT, Lim IJ et al. Differential transcriptional responses of keloid and normal keratinocytes to serum stimulation. J Surg Res 2006 135 : 156 163.
16. Xia W, Longaker MT, Yang GP. P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts. Am J Physiol Regul Integr Comp Physiol 2006 290 : R501 8.
17. Matsuzaki K. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis. Histol Histopathol 2006 21 : 645 662.
18. He SF, Yang L, Huang WJ et al. Detection of PAI-1mRNA expression induced by TGF-β1 in keloid fibroblasts using real-time fluorescence quantitative RT-PCR method. Chin Pharmacol Bull 2009 25 : 1261 1264.
19. Tuan TL, Wu H, Huang EY et al. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 2003 162 : 1579 1589.
20. Nakao A, Afrakhte M, Moren A et al. Identification of Smad7, a TGF-beta-inducible antagonist of TGF-beta signalling. Nature 1997 389 : 631 635.
21. Furukawa F, Matsuzaki K, Mori S et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003 38 : 879 889.
22. Verrecchia F, Mauviel A. Transforming growth factor-β signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002 118 : 211 215.
23. Xu L. Regulation of Smad activities. Biochim Biophys Acta 2006 1759 : 503 513.
24. Matsuzaki K, Okazaki K. Transforming growth factor-b during carcinogenesis: the shift from epithelial to mesenchymal signaling. J Gastroenterol 2006 41 : 295 303. (Pubitemid 43834371)
25. Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci 2009 14 : 2923 2934.
26. Babu M, Diegelmann R, Oliver N. Keloid fibroblasts exhibit an altered response to TGF-β1. J Invest Dermatol 1992 99 : 650 655.
27. Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 2005 24 : 5742 5750.
28. Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 2005 280 : 1024 1036.
29. Sekimoto G, Matsuzaki K, Yoshida K et al. Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res 2007 67 : 5090 5096.
30. Kretzschmar M, Doody J, Timokhina I et al. A mechanism of repression of TGF-beta/Smad signaling by oncogenic Ras. Genes Dev 1999 13 : 804 816.
31. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003 113 : 685 700.
32. Mori S, Matsuzaki K, Yoshida K et al. TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 2004 23 : 7416 7429.
33. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-family signalling. Nature 2003 425 : 577 584.
34. Yang Y, Yang S, Chen MZ et al. Compound Astragalus and Salvia miltiorrhiza extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. J Ethnopharmacol 2008 118 : 264 270.
35. Wu Y, Zhang Q, Ann DK et al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 2004 286 : C905 12.
36. Zhang Q, Wu Y, Ann DK et al. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 2003 121 : 1005 1012.
37. Zhang Q, Wu Y, Chau CH et al. Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts. J Cell Physiol 2004 199 : 89 97.
38. Kopp J, Preis E, Said H et al. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem 2005 280 : 21570 21576.
39. Yu H, Bock O, Bayat A et al. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg 2006 59 : 221 229.